Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Clinical trial NCT02151149 · COMPLETED

Trial details

NCT number: NCT02151149
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Carcinoma Squamous Cell Carcinoma Adenocarcinoma Carcinoma, Large Cell Lung Neoplasm

Start date: 2014-06-09
Primary completion: 2017-07-14
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.